Clinical Trials Directory

Trials / Sponsors / Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Lupus Nephritis
Phase 22023-11-03
CompletedA Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
Autoimmune Hepatitis
Phase 22023-05-23
TerminatedKZR-261 in Subjects With Advanced Solid Malignancies
Advanced/Metastatic Solid Tumor
Phase 12021-09-30
CompletedOpen-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
Polymyositis, Dermatomyositis
Phase 22020-11-04
WithdrawnA Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
Autoimmune Hemolytic Anemia, Immune Thrombocytopenia
Phase 22020-07-01
CompletedA Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyos
Polymyositis, Dermatomyositis
Phase 22020-01-14
CompletedA Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
Lupus Nephritis, Systemic Lupus Erythematosus
Phase 1 / Phase 22018-02-20
Kezar Life Sciences, Inc. — clinical trials (7) · Clinical Trials Directory